1jpp: Difference between revisions

Revision as of 20:36, 1 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:1jpp.png

Template:STRUCTURE 1jpp

The Structure of a beta-Catenin Binding Repeat from Adenomatous Polyposis Coli (APC) in Complex with beta-CateninThe Structure of a beta-Catenin Binding Repeat from Adenomatous Polyposis Coli (APC) in Complex with beta-Catenin

Template:ABSTRACT PUBMED 11707392

About this StructureAbout this Structure

1JPP is a Protein complex structure of sequences from Mus musculus. Full crystallographic information is available from OCA.

ReferenceReference

Molecular mechanisms of beta-catenin recognition by adenomatous polyposis coli revealed by the structure of an APC-beta-catenin complex., Eklof Spink K, Fridman SG, Weis WI, EMBO J. 2001 Nov 15;20(22):6203-12. PMID:11707392

Page seeded by OCA on Tue Jul 1 20:36:25 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:1jpp.gif|left|200px]]
+{{Seed}}
+[[Image:1jpp.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_1jpp|  PDB=1jpp  |  SCENE=  }}
-'''The Structure of a beta-Catenin Binding Repeat from Adenomatous Polyposis Coli (APC) in Complex with beta-Catenin'''
+===The Structure of a beta-Catenin Binding Repeat from Adenomatous Polyposis Coli (APC) in Complex with beta-Catenin===
-==Overview==
+<!--
-The adenomatous polyposis coli (APC) tumor suppressor protein plays a critical role in regulating cellular levels of the oncogene product beta-catenin. APC binds to beta-catenin through a series of homologous 15 and 20 amino acid repeats. We have determined the crystal structure of a 15 amino acid beta-catenin binding repeat from APC bound to the armadillo repeat region of beta-catenin. Although it lacks significant sequence homology, the N-terminal half of the repeat binds in a manner similar to portions of E-cadherin and XTcf3, but the remaining interactions are unique to APC. We discuss the implications of this new structure for the design of therapeutics, and present evidence from structural, biochemical and sequence data, which suggest that the 20 amino acid repeats can adopt two modes of binding to beta-catenin.
+The line below this paragraph, {{ABSTRACT_PUBMED_11707392}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 11707392 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_11707392}}
 ==About this Structure==
@@ Line 28: / Line 32: @@
 [[Category: Disease mutation]]
 [[Category: Repeat]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May  2 21:34:02 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul  1 20:36:25 2008''